iOmx doses first patient in pivotal phase 1 study by John Pinching | Apr 4, 2023 | News | 0 Study becomes the first-in-human clinical trial involving OMX-0407 in a specific patient group Read More
ABPI’s Patient Advisory Council boosted by new leaders by John Pinching | Apr 3, 2023 | News | 0 Five vital new appointments made to regulator’s insight, perspective and advice group Read More
Small Pharma begins phase 1 mental health therapy trial by John Pinching | Feb 16, 2023 | News | 0 First subject dosed with company’s SPL028 – a proprietary deuterated DMT candidate Read More
Pharma & patient organisation collaborations could ‘improve patient care’ by Anna Smith | Aug 8, 2019 | News | 0 The survey revealed that patients, regardless of their country or disease state, highly value services from patient organisations and prefer them over those from pharmaceutical companies. Read More